Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies

Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies

Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the secretion of several substances, occurring in about 10–40% of patients with well-differentiated neuroendocrine tumors (NETs). The main signs and symptoms associated with carcinoid syndrome are flushing, diarrhea, hypo...

Full description

Bibliographic Details
Main Authors: Giovanni Vitale, Silvia Carra, Ylenia Alessi, Federica Campolo, Carla Pandozzi, Isabella Zanata, Annamaria Colao, Antongiulio Faggiano, on behalf of the NIKE Group
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Molecular Sciences
Subjects:
carcinoid syndrome
preclinical models
neuroendocrine tumors
serotonin
xenograft
pharmacological treatment
Online Access:https://www.mdpi.com/1422-0067/24/4/3610

Internet

https://www.mdpi.com/1422-0067/24/4/3610

Similar Items